MD, DNB Internal Medicine & DNB Cardiology with 12 yrs of experience. Hyd
Focuses on benefits of ARNI (First in class Angiotensin reseptor, Neprilysin Inhibitor) Presently approved for the treatment of heart failure with reduce eggection factor when initiated pre-discharge and continued post discharge.